Jun 10, 2026
The life sciences industry is in the midst of a quiet revolution, one that is unfolding not in sprawling clinical trial sites or blockbuster FDA approvals, but inside compact laboratory incubators where miniature, self-organizing replicas of human organs are being grown, monitored, and analyzed at unprecedented sca...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper